AnGes’. $250 Million Acquisition of EmendoBio

Morgan, Lewis & Bockius LLP represented EmendoBio in the transaction. AnGes, Inc., a commercial stage Japanese biopharmaceutical company focused on gene-based medicines, completed the acquisition of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here